Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02852252 · ClinicalTrials.gov registry record
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 291
- Enrollment target
NCT02852252: Completed study, sponsored by University of Pennsylvania.
NCT02852252 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 291 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02852252 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 291 participants
- Enrollment target
Study Summary
The study objective is to collect prospective data on cancer patients who undergo surgery and intraoperative imaging. The registry will include (but not limited to) cancer type, stage, intraoperative challenges to the surgeon, usage and results of intraoperative imaging, and recurrence surveillance.
Primary Outcome
Enhance ability to detect malignant tissues in situ and ex vivo.
Interventions
- DRUG ICG
- DRUG OTL38
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2016-07 |
| Est. Completion | 2020-02 |
What the finished NCT02852252 record still lists
NCT02852252 is an observational study that tracks outcomes without assigning an intervention. The registered 291 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which ICG is the first listed.
NCT02852252 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02852252 about?
NCT02852252 is a clinical study titled "Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry". The study objective is to collect prospective data on cancer patients who undergo surgery and intraoperative imaging. The registry will include (but not limited to) cancer type, stage, intraoperative challenges to the surgeon, usage and results of intraoperative imaging, and recurrence surveillance.
What is the current status of trial NCT02852252?
This trial is currently completed. The enrollment target is 291 participants. The study started on 2016-07. Estimated completion is 2020-02.
What interventions are being tested in trial NCT02852252?
The interventions under investigation include: ICG (DRUG), OTL38 (DRUG).
Who is sponsoring clinical trial NCT02852252?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02074839 · 291 participants · Phase 1
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- NCT03769766 · 291 participants · Phase 3
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
- NCT06563479 · 291 participants · Phase 3
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia